Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.65 |
| ▸ | MAOA | P21397 | 3/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.65 |
| ▸ | SDHA | P31040 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | CALML3 | P27482 | 1/20 | 0.65 |
| ▸ | F10 | P00742 | 12/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21634814 | 1.00 | MAOB (0.65) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL21634733 | 0.92 | MAOB (0.78) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL21634731 | 0.92 | MAOB (0.78) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL18396810 | 0.91 | MAOB (0.62) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL18396811 | 0.91 | MAOB (0.62) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL31150317 | 0.90 | MAOB (0.65) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL3570302 | 0.88 | MAOB (0.75) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL3570299 | 0.88 | MAOB (0.75) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL21634956 | 0.88 | MAOA (0.48) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL21634955 | 0.88 | MAOA (0.48) | MAOBMAOAPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020021468-A1 | SUBSTITUTED OXAZOLIDINONES FOR THE TREATMENT OF MAMMALIAN INFECTIONS | CADILA HEALTHCARE LIMITED (IN) | 2020-01-30 | — | — | WO | claimed |
| WO-2020021468-A1 | SUBSTITUTED OXAZOLIDINONES FOR THE TREATMENT OF MAMMALIAN INFECTIONS | CADILA HEALTHCARE LIMITED (IN) | 2020-01-30 | — | — | WO | disclosed |